The mean annual and lifetime costs of glaucoma treatment per patient.*
| Overall | Non-drug | Drug | |
|---|---|---|---|
| (N=100) | (N=100) | (N=106) | |
| Mean cost per patient per year | £475 (95% CI £136 to £1128) | £319 (95% CI £21 to £1029) | £157 (95% CI £32 to £312) |
| Mean lifetime cost | £3001 (95% CI £494 to £7489) | £1972 (95% CI £165 to £6558) | £1030 (95% CI £115 to £2501) |
*Includes costs of the following drugs: Alphagan (Allergan, Irvine, USA), Azopt, Betagan (Allergan, Irvine, USA), Betoptic, Cosopt (MSD, NJ, USE), Diamox (Goldshield Pharmaceuticals, Croydon, UK), Lumigan (Allergan, Irvine, USA), Pilocarpine, Pilogel, Propine, Timoptol, Travatan (Alcon, Fort Worth, USA), Trusopt (MSD, NJ, USE), Xalacom (Pfizer, New York, USA) and Xalatan (Pfizer, New York, USA).